Lookup NU author(s): Duncan Miller
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The voltage gated sodium channel NaV1.8 has been postulated to play a key role in the transmission of pain signals. Core hopping from our previously reported phenylimidazole leads has allowed the identification of a novel series of benzimidazole NaV1.8 blockers. Subsequent optimization allowed the identification of compound 9, PF-06305591, as a potent, highly selective blocker with an excellent preclinical in vitro ADME and safety profile.
Author(s): Brown AD, Bagal SK, Blackwell P, Blakemore DC, Brown B, Bungay PJ, Corless M, Crawforth J, Fengas D, Fenwick DR, Gray V, Kenp M, Klute W, Malet-Sainz L, Miller D, Murata YC, Payne E, Skerratt S, Warmus JS
Publication type: Article
Publication status: Published
Journal: Bioorganic & Medicinal Chemistry
Print publication date: 01/01/2019
Online publication date: 04/12/2018
Acceptance date: 01/12/2018
ISSN (print): 0968-0896
ISSN (electronic): 1464-3391
Altmetrics provided by Altmetric